CytomX Therapeutics
CTMX
CTMX
113 hedge funds and large institutions have $264M invested in CytomX Therapeutics in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.25% more ownership
Funds ownership: 78.67% → 78.92% (+0.25%)
34% less capital invested
Capital invested by funds: $400M → $264M (-$135M)
Holders
113
Holding in Top 10
–
Calls
$86K
Puts
$9K
Top Buyers
| 1 | +$6.49M | |
| 2 | +$4.69M | |
| 3 | +$1.72M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$1.66M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$1.44M |
Top Sellers
| 1 | -$4.4M | |
| 2 | -$3.71M | |
| 3 | -$3.24M | |
| 4 |
Millennium Management
New York
|
-$3.03M |
| 5 |
Morgan Stanley
New York
|
-$2.26M |